HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Laura Pike Selected Research
Laura Pike Research Topics
Disease
2
Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
07/2013 - 09/2012
1
Neoplasms (Cancer)
01/2020
1
Anaplastic Thyroid Carcinoma
01/2018
1
Thyroid Neoplasms (Thyroid Cancer)
05/2015
1
Febrile Neutropenia
07/2013
1
Stomatitis
07/2013
1
Colorectal Neoplasms (Colorectal Cancer)
10/2012
1
Dysphonia (Spastic Dysphonia)
03/2012
1
Renal Cell Carcinoma (Grawitz Tumor)
03/2012
1
Hypertension (High Blood Pressure)
03/2012
1
Fatigue
03/2012
Drug/Important Bio-Agent (IBA)
2
2- ((3- ((4- ((5- (2- ((3- fluorophenyl)amino)- 2- oxoethyl)- 1H- pyrazol- 3- yl)amino)quinazolin- 7- yl)oxy)propyl)(ethyl)amino)ethyl dihydrogen phosphate
IBA
07/2013 - 09/2012
2
Aurora Kinase B
IBA
07/2013 - 09/2012
2
cediranib (AZD2171)
IBA
10/2012 - 03/2012
1
Pharmaceutical Preparations
IBA
01/2020
1
Bexarotene (LGD1069)
FDA Link
05/2015
1
Cytarabine (Cytosar-U)
FDA Link
Generic
07/2013
1
Fluorouracil (Carac)
FDA Link
Generic
10/2012
1
Capecitabine (Xeloda)
FDA Link
10/2012
1
Leucovorin (Folinic Acid)
FDA Link
10/2012
1
Oxaliplatin (Eloxatin)
FDA Link
Generic
10/2012
1
Bevacizumab (Avastin)
FDA Link
10/2012
1
Prodrugs
IBA
09/2012
1
Phosphoric Monoester Hydrolases (Phosphatases)
IBA
09/2012
1
AZD 1152-HQPA
IBA
09/2012
1
Vascular Endothelial Growth Factor Receptors (VEGF Receptors)
IBA
03/2012
1
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
03/2012
Therapy/Procedure
1
Therapeutics
01/2018
1
Radiotherapy
01/2018
1
Drug Therapy (Chemotherapy)
10/2012